Examkin

Tüm alıştırma soruları

8270 soru

Tüm türler8,270Çoktan seçmeli4,249Çoklu seçim325Sayısal160Eşleştirme1,849Sıralama1,687
Soru 4061Soru →

A 63-year-old woman comes to the clinic for a routine health maintenance examination. She feels well and has no specific complaints. She underwent natural menopause at age 51 and has had no subsequent vaginal bleeding. Her past medical history is significant for severe, seropositive rheumatoid arthritis, which has been well-controlled for the past five years on a regimen of weekly methotrexate and daily low-dose prednisone (5 mg5 \text{ mg} daily). She has never smoked and consumes alcohol rarely. Her blood pressure is 118/76 mmHg118/76 \text{ mmHg}, heart rate is 72/min72/\text{min}, and BMI is 22 kg/m222 \text{ kg/m}^2. Her most recent screening mammogram was performed 6 months ago and was normal. She had a screening colonoscopy at age 58, which revealed no polyps or abnormalities. She received the 20-valent pneumococcal conjugate vaccine (PCV20) and the recombinant zoster vaccine series at age 62. Her most recent Pap smear and HPV cotesting at age 61 were negative, following a history of consistently negative cervical screenings. Which of the following is the most appropriate next step in preventive care for this patient?

Cevabı ve açıklamayı göster

Cevap: Dual-energy x-ray absorptiometry scan

Cevap

Dual-energy x-ray absorptiometry scan
The most appropriate next step in preventive care for this patient is a dual-energy x-ray absorptiometry (DEXA) scan. The United States Preventive Services Task Force (USPSTF) recommends osteoporosis screening for women aged 65 and older, as well as for postmenopausal women younger than 65 who are at an increased risk of osteoporosis. This patient has multiple significant clinical risk factors that lower her bone mineral density, including a history of rheumatoid arthritis and chronic, long-term use of systemic glucocorticoids (prednisone). These factors independently accelerate bone loss and significantly increase her fracture risk, making early screening with a DEXA scan the standard of care.

Adım Adım Çözüm

1
Evaluate the patient's current age, medical conditions, and medications against preventive care guidelines.
The patient is a 63-year-old postmenopausal woman with rheumatoid arthritis on chronic glucocorticoids and methotrexate.
Age, medical history, and current immunosuppressive medications directly dictate screening eligibility and vaccine safety.
2
Assess the need for osteoporosis screening based on age and clinical risk factors.
Although she is under 65, her chronic prednisone use and rheumatoid arthritis place her at high risk for accelerated bone loss and fractures, meeting the criteria for early screening.
The USPSTF recommends bone measurement testing for postmenopausal women younger than 65 who have an increased risk of osteoporosis based on a clinical risk assessment tool.
3
Evaluate the remaining options to rule out non-indicated or contraindicated interventions.
She is up to date on cancer screenings (breast, colon, cervical). Endometrial biopsy, ovarian cancer screening, and asymptomatic bacteriuria screening are not recommended. Live vaccines (like MMR) are contraindicated.
Eliminating distractors confirms that the bone density scan is the only indicated and safe preventive intervention for this patient.

Anahtar Kavram

The USPSTF recommends screening for osteoporosis with bone measurement testing (DEXA) in postmenopausal women younger than 65 years who are at increased risk of osteoporosis, such as those with rheumatoid arthritis or chronic glucocorticoid use.
Soru 4062Soru →

A 71-year-old male is assessed in the intensive care unit on postoperative day 3 following an emergent open repair of a ruptured abdominal aortic aneurysm. His past medical history includes chronic obstructive pulmonary disease, ischemic cardiomyopathy, and hypertension. Over the past several hours, he has developed worsening generalized abdominal pain and just passed a large amount of dark, bloody stool. He also complains of new-onset shortness of breath. Vital signs are temperature 38.6°C (101.5°F), blood pressure 82/50 mm Hg, pulse 130/min, and respirations 26/min. Pulse oximetry is 92% on a nasal cannula. Physical examination reveals a markedly distended, rigid abdomen with diffuse tenderness and involuntary guarding. Bowel sounds are absent. Lung auscultation demonstrates scattered expiratory wheezes. Laboratory results are notable for a leukocyte count of 22,000/mm³ and a serum lactate of 6.8 mmol/L. Despite an initial bolus of intravenous crystalloid, his blood pressure remains 84/52 mm Hg. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Emergent exploratory laparotomy

Cevap

Emergent exploratory laparotomy
The correct answer is emergent exploratory laparotomy. This patient is presenting with classic signs of acute colonic ischemia (severe abdominal pain, bloody diarrhea) following an open abdominal aortic aneurysm (AAA) repair. During open AAA repair, the inferior mesenteric artery (IMA) is often sacrificed. While collateral circulation from the superior mesenteric artery (via the marginal artery of Drummond) is usually sufficient, patients with poor collaterals or periods of perioperative hypotension are at high risk for colonic ischemia, particularly at the splenic flexure (Griffith's point) and rectosigmoid junction (Sudeck's point). This patient has developed full-thickness bowel necrosis leading to perforation, evident by his rigid abdomen with involuntary guarding (peritonitis) and septic shock (hypotension despite fluid resuscitation, fever, marked leukocytosis, and severe lactic acidosis). The presence of peritonitis in a hemodynamically unstable patient is an absolute indication for immediate surgical exploration to resect the dead bowel.

Adım Adım Çözüm

1
Analyze the patient's symptoms and surgical history
The patient is status post open abdominal aortic aneurysm (AAA) repair and presents with bloody diarrhea and severe abdominal pain.
During open AAA repair, the inferior mesenteric artery (IMA) is often ligated, placing the patient at high risk for acute colonic ischemia, particularly in watershed areas like the splenic flexure.
2
Evaluate the patient's hemodynamic status and physical examination findings
The patient is in distributive (septic) shock (hypotension unresponsive to fluids, tachycardia, fever, high lactate) and has a rigid, distended abdomen with involuntary guarding.
These findings indicate that the colonic ischemia has progressed to full-thickness bowel infarction and perforation, leading to severe peritonitis.
3
Determine the appropriate intervention based on stability and examination
The next step is emergent exploratory laparotomy.
Hemodynamically unstable patients with peritonitis must bypass diagnostic imaging and be taken immediately to the operating room for life-saving resection of the necrotic bowel.

Anahtar Kavram

Management of acute colonic ischemia following abdominal aortic aneurysm repair
Tahmini Süre:1m 30s
Soru 4063Soru →

A national health ministry implements a two-step diagnostic protocol for a newly identified infectious pathogen. The protocol dictates that all individuals in a high-risk region first undergo a rapid biomarker assay. Only those who test positive on this initial screening proceed to a highly specific nucleic acid amplification test (NAAT) for definitive diagnosis. After two months of implementation, laboratory bottlenecks prompt the ministry to alter the diagnostic cutoff for the rapid biomarker assay, requiring a significantly higher biomarker concentration to trigger a "positive" result. Assuming the true prevalence of the infection in the region remains constant, which of the following is the most likely consequence of this policy change on the testing protocol's performance metrics?

Cevabı ve açıklamayı göster

Cevap: The negative predictive value of the nucleic acid amplification test will decrease.

Cevap

The negative predictive value of the nucleic acid amplification test will decrease.
Raising the diagnostic cutoff for the rapid biomarker assay makes the test more stringent, which increases its specificity (fewer false positives) and decreases its sensitivity (more false negatives). In a screening protocol, the decrease in false positives increases the positive predictive value (PPV) of the rapid assay. Because only patients who test positive on the rapid assay proceed to the nucleic acid amplification test (NAAT), the PPV of the rapid assay serves as the pre-test probability (prevalence) for the NAAT. An increase in the pre-test probability of a disease mathematically results in a decreased negative predictive value (NPV) for any subsequent test, as a negative result is less likely to be a true negative when the disease is more common in the tested population.

Adım Adım Çözüm

1
Determine the effect of a higher diagnostic cutoff on the rapid biomarker assay's sensitivity and specificity.
Sensitivity decreases and specificity increases.
A higher diagnostic threshold requires more biomarker to be present to trigger a positive result, meaning fewer true cases will be detected (lower sensitivity) and fewer healthy individuals will be incorrectly flagged (higher specificity).
2
Determine the effect of these changes on the positive predictive value (PPV) of the rapid biomarker assay.
The PPV of the rapid biomarker assay increases.
The increase in specificity significantly reduces the number of false positives. In screening populations, reducing false positives is the primary driver for increasing the positive predictive value.
3
Identify the pre-test probability for the subsequent nucleic acid amplification test (NAAT).
The pre-test probability for the NAAT is equal to the PPV of the rapid biomarker assay.
Because only patients who test positive on the rapid assay proceed to the NAAT, the prevalence of disease in this newly tested subgroup is exactly the PPV of the first test.
4
Determine the effect of an increased pre-test probability on the NAAT's negative predictive value (NPV).
The NPV of the NAAT decreases.
When disease prevalence (pre-test probability) increases, a negative test result is less reliable because there are more true cases in the population that could yield false negatives.

Anahtar Kavram

In a sequential testing protocol, the positive predictive value of the initial screening test becomes the pre-test probability for the confirmatory test. Raising a test's cutoff increases its specificity and PPV, which consequently decreases the NPV of the subsequent confirmatory test.
Soru 4064Soru →

A 28-year-old man presents to the clinic for routine health maintenance and sexually transmitted infection screening. He reports having unprotected receptive anal intercourse with a new male partner 4 weeks ago. He is completely asymptomatic and has no history of opportunistic infections. His vital signs and physical examination are unremarkable. The physician decides to initiate the standard Centers for Disease Control and Prevention (CDC) recommended HIV testing algorithm.

Assuming the patient was recently infected and is currently in the acute phase of HIV, arrange the following diagnostic and management steps in the correct chronological sequence from first to last.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence follows the standard CDC HIV diagnostic algorithm: initial combination immunoassay, followed by antibody differentiation, then nucleic acid testing to confirm acute infection, followed by rapid ART initiation, and finally longitudinal disease monitoring.
The sequence follows the standard CDC diagnostic algorithm for HIV testing. Initial screening begins with a fourth-generation antigen/antibody combination assay. If reactive, it is followed by an HIV-1/HIV-2 antibody differentiation assay. In a patient with suspected acute HIV infection (who will often have a negative or indeterminate differentiation assay due to a lack of mature antibodies), an HIV-1 nucleic acid test (NAT) is required to establish the diagnosis. Following confirmation of acute infection, the immediate clinical priority is the rapid initiation of antiretroviral therapy. Long-term management then relies on routine monitoring of the CD4 cell count and HIV viral load.

Adım Adım Çözüm

1
Identify the recommended initial screening test.
Fourth-generation HIV-1/2 antigen/antibody combination immunoassay.
This is the highly sensitive first step in the modern HIV screening algorithm capable of detecting early infection via the p24 antigen.
2
Determine the next step for a reactive initial screening test.
HIV-1/HIV-2 antibody differentiation immunoassay.
A reactive initial screen must be confirmed and typed to differentiate between HIV-1 and HIV-2.
3
Determine the confirmatory test for acute infection when the differentiation assay is negative or indeterminate.
HIV-1 nucleic acid test (NAT).
During the acute window period, antibodies are not yet present in sufficient quantities, but viral RNA is highly detectable.
4
Identify the immediate management step upon confirming acute HIV infection.
Rapid initiation of antiretroviral therapy (ART).
Immediate ART initiation is recommended to preserve immune function, reduce the viral reservoir size, and prevent transmission.
5
Determine the long-term management plan.
Longitudinal monitoring of viral load and CD4 cell count.
Lifelong surveillance is required to evaluate ART efficacy, ensure virologic suppression, and monitor immune recovery.

Anahtar Kavram

The standard CDC HIV screening algorithm for acute infection consists of a sequential cascade: a 4th-generation antigen/antibody combination assay, followed by an antibody differentiation immunoassay, and if indeterminate/negative (indicating acute infection), an HIV-1 nucleic acid test (NAT).
Soru 4065Soru →

A public health committee is evaluating modifications to various screening and diagnostic protocols. These modifications involve either adjusting the diagnostic cutoff thresholds for continuous biomarkers or applying existing tests to populations with different baseline disease prevalences. Match each protocol modification (left) with its expected primary effect on the test's performance characteristics (right).

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Raising the required serum concentration threshold of a biomarker to report a test as positive
Lowering the diagnostic cutoff value of a screening assay to ensure fewer cases are missed
Implementing an existing diagnostic test in a highly symptomatic tertiary care cohort rather than the general public
Applying a disease-specific screening test to a general population with an extremely low baseline disease burden

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Raising a cutoff decreases false positives and increases false negatives. Lowering a cutoff increases false positives and decreases false negatives. Increasing disease prevalence increases PPV and decreases NPV. Decreasing disease prevalence decreases PPV and increases NPV.
Changes in test cutoffs directly alter sensitivity and specificity (affecting false negatives and false positives), whereas changes in population prevalence directly alter positive and negative predictive values. Strict cutoffs limit false positives; relaxed cutoffs limit false negatives. High prevalence yields high PPV; low prevalence yields low PPV.

Adım Adım Çözüm

1
Evaluate the effect of altering diagnostic cutoff thresholds on inherent test parameters.
Raising the threshold decreases false positives and increases false negatives. Lowering the threshold increases false positives and decreases false negatives.
Cutoff shifts alter the inherent sensitivity and specificity of the test by changing the required strictness for a positive result.
2
Evaluate the effect of altering population disease prevalence on predictive values.
Testing in a higher prevalence population increases PPV and decreases NPV. Testing in a lower prevalence population decreases PPV and increases NPV.
Prevalence shifts affect how likely a test result represents the true disease state (predictive values) without altering the test's inherent sensitivity or specificity.

Anahtar Kavram

Impact of cutoff threshold adjustments and disease prevalence on diagnostic test performance characteristics
Soru 4066Soru →

A 45-year-old asymptomatic man with no significant past medical history presents for a routine wellness examination. He has not seen a physician in over a decade. He takes no medications and has no known risk factors for viral hepatitis. The physician decides to implement age-appropriate clinical preventive services.

Arrange the following steps in the correct chronological sequence for this patient's Hepatitis C screening and subsequent management, assuming positive or abnormal findings at each diagnostic step.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: HCV antibody testing, followed by HCV RNA testing, hepatic fibrosis assessment, initiation of DAA therapy, and finally measuring HCV RNA 12 weeks post-treatment.
The standard of care for Hepatitis C screening and management follows a strict clinical cascade. It begins with universal one-time screening using the HCV antibody test for all adults aged 18 to 79. Because antibodies persist even after spontaneous clearance, a positive screen must be followed by an HCV RNA PCR test to confirm active viremia. Once active infection is confirmed, non-invasive assessment of hepatic fibrosis (such as transient elastography or FIB-4) must be performed before starting treatment; this dictates the specific regimen and identifies the need for lifelong hepatocellular carcinoma surveillance in cirrhotic patients. Following fibrosis staging, pan-genotypic direct-acting antiviral (DAA) therapy is initiated. Finally, virologic cure is confirmed by documenting a sustained virologic response (SVR), which requires an undetectable HCV RNA level 12 weeks after therapy completion.

Adım Adım Çözüm

1
Identify the indication for initial screening.
The patient meets criteria for universal one-time HCV screening (adults aged 18-79).
USPSTF guidelines mandate universal screening to detect asymptomatic carriers and reduce long-term morbidity.
2
Determine the confirmatory test following a positive screen.
HCV RNA PCR is ordered.
Antibodies remain positive lifelong even if the infection was spontaneously cleared; RNA confirms active viremia.
3
Identify the mandatory pre-treatment evaluation.
Hepatic fibrosis assessment is performed.
Fibrosis staging dictates the treatment regimen and long-term hepatocellular carcinoma surveillance needs.
4
Select the appropriate therapeutic intervention.
Pan-genotypic DAA therapy is initiated.
DAAs are the standard of care for eradicating confirmed, active HCV infection.
5
Determine the protocol for confirming cure.
HCV RNA is measured 12 weeks post-treatment.
This establishes a Sustained Virologic Response (SVR), which equates to a clinical cure.

Anahtar Kavram

The clinical cascade for Hepatitis C includes universal antibody screening, RNA confirmation of active infection, fibrosis staging prior to treatment, DAA therapy, and documentation of Sustained Virologic Response (SVR).
Tahmini Süre:1m 30s
Soru 4067Soru →

An emergency medical services team rushes a 71-year-old woman to the emergency department after she experienced an abrupt onset of agonizing, diffuse abdominal pain 2 hours ago. She has a medical history of paroxysmal atrial fibrillation (for which she has not been taking her prescribed oral anticoagulant), type 2 diabetes mellitus, and chronic bronchitis. Her temperature is 37.4°C (99.3°F), blood pressure is 82/50 mmHg, pulse is 134/min and irregularly irregular, and respirations are 28/min. Physical examination reveals a diaphoretic, lethargic patient writhing in pain. Lung auscultation demonstrates prolonged expiration with scattered end-expiratory wheezes. The abdomen is markedly distended and extremely tender to light palpation in all quadrants, with board-like rigidity and involuntary guarding. Bowel sounds are absent.

Arterial blood gas analysis on room air reveals:
pH: 7.18
pCO2pCO_2: 30 mmHg
pO2pO_2: 65 mmHg
HCO3−HCO_3^-: 11 mEq/L

Serum lactate is 9.2 mmol/L.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Immediate transfer to the operating room for abdominal exploration

Cevap

Immediate transfer to the operating room for abdominal exploration
The patient's presentation of abrupt, severe abdominal pain in the setting of unanticoagulated atrial fibrillation is classic for acute mesenteric ischemia caused by an arterial embolus. The development of hemodynamic instability (blood pressure 82/50 mmHg), profound lactic acidosis (9.2 mmol/L), and frank peritonitis (board-like rigidity and involuntary guarding) indicates that the ischemia has advanced to transmural bowel infarction. In any patient presenting with an acute surgical abdomen and shock, the correct next step is emergent exploratory laparotomy to remove necrotic bowel and restore perfusion.

Adım Adım Çözüm

1
Identify the primary pathology based on the clinical presentation.
The combination of sudden severe abdominal pain and unanticoagulated atrial fibrillation points to an acute superior mesenteric artery embolus.
Atrial fibrillation predisposes to mural thrombus formation, which can embolize to the mesenteric vessels.
2
Assess the patient's hemodynamic and abdominal status.
The patient exhibits hypotension, tachycardia, a rigid abdomen with involuntary guarding (peritonitis), and profound lactic acidosis.
These findings indicate that the ischemia has progressed to transmural bowel infarction and septic/hypovolemic shock.
3
Determine the most appropriate management for the current clinical state.
The patient must be taken immediately to the operating room for an exploratory laparotomy.
Hemodynamically unstable patients with an acute surgical abdomen (peritonitis) require emergent surgical exploration to resect necrotic tissue; advanced diagnostic imaging will critically delay life-saving treatment.

Anahtar Kavram

Management of complicated acute mesenteric ischemia
Soru 4068Soru →

Investigators are designing a prospective, randomized controlled trial to evaluate the efficacy of a novel continuous positive airway pressure (CPAP) mask in reducing daytime somnolence among patients with moderate obstructive sleep apnea. The primary outcome is the mean change in the Epworth Sleepiness Scale (ESS) score after 88 weeks of use, compared to the standard CPAP mask. A pilot study of 3030 patients (1515 per group) reveals a mean ESS reduction of 4.24.2 points (standard deviation: 2.12.1) in the novel mask group and 2.82.8 points (standard deviation: 2.42.4) in the standard mask group. An unpaired t-test yields a p-value of 0.100.10. The 95%95\% confidence interval for the difference in means is [−0.3,3.1][-0.3, 3.1]. Based on these preliminary results, the research team decides to halt the development of the novel mask, concluding that it does not provide a superior clinical benefit. Which of the following is the most accurate critique of the investigators' statistical conclusion?

Cevabı ve açıklamayı göster

Cevap: The study likely lacked sufficient statistical power, risking a Type II error due to the small sample size.

Cevap

The study likely lacked sufficient statistical power, risking a Type II error due to the small sample size.
The correct answer accurately identifies that a small pilot study (n=30n=30) evaluating a continuous variable (ESS score) will naturally have low statistical power. The study observed a clinically notable difference (1.41.4 point reduction), but the wide confidence interval crossing zero and p=0.10p = 0.10 indicate insufficient evidence to reject the null hypothesis. Halting development solely on this basis ignores the high probability of a Type II error (failing to detect a true difference due to inadequate sample size).

Adım Adım Çözüm

1
Analyze the statistical outputs provided in the stem.
The difference in means is 1.41.4. The p-value is 0.100.10, and the 95%95\% CI is [−0.3,3.1][-0.3, 3.1].
Understanding the clinical outcome versus the statistical significance threshold (typically α=0.05\alpha = 0.05) is required to interpret the results.
2
Evaluate the sample size and its mathematical relationship to the statistical findings.
The sample size is very small (n=30n=30, with 1515 per group). Small sample sizes produce large standard errors, resulting in wide confidence intervals that are more likely to cross zero.
Statistical power is heavily dependent on sample size. A small sample size directly limits a study's ability to detect a true difference.
3
Identify the logical flaw in the investigators' conclusion.
The investigators concluded the mask has NO benefit because p>0.05p > 0.05. However, failing to reject the null hypothesis in an underpowered study suggests a high risk of a Type II error (β\beta).
Concluding that an intervention is ineffective simply because a severely underpowered pilot study did not reach statistical significance is a fundamental misinterpretation of hypothesis testing.

Anahtar Kavram

Statistical power and Type II error
Tahmini Süre:1m 30s
Soru 4069Soru →

A team of public health researchers has been following a cohort of 80,000 initially healthy adults for the past 15 years to study cardiovascular risk factors. During the follow-up period, participants provided annual blood samples that were cryopreserved, and they completed detailed health questionnaires. Recently, a novel inflammatory marker, biomarker XX, was hypothesized to be associated with the development of a rare subtype of lymphoma.

Testing all 80,000 samples for biomarker XX is cost-prohibitive. Instead, the researchers identify the 65 participants who developed this lymphoma during the 15-year follow-up. For each of these 65 individuals, they randomly select four participants from the cohort who remained free of the lymphoma at the time of the case's diagnosis, matching them by age and sex. The researchers then thaw the baseline blood samples for these 325 individuals to measure and compare the levels of biomarker XX.

Which of the following statements regarding this epidemiological study are correct? (Select 2)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: This study design minimizes recall bias because the biological specimens were collected prior to disease onset.; The appropriate primary measure of association to calculate for this analysis is the odds ratio.

Cevap

The correct statements are that the design minimizes recall bias due to prospective specimen collection, and the appropriate measure of association is the odds ratio.
The scenario describes a nested case-control study. In this design, cases of a disease that occur in a defined cohort are identified, and for each case, a specified number of matched controls are selected from those in the cohort who have not developed the disease. Because the biological samples (exposure data) were collected prospectively before the disease developed, recall bias and temporal ambiguity are minimized. Like all case-control studies, the subjects for the analysis are selected based on their disease status (lymphoma vs. no lymphoma), meaning the appropriate measure of association is the odds ratio.

Adım Adım Çözüm

1
Identify the study design from the sampling methodology.
The study is a nested case-control study.
Researchers selected subjects based on disease status (lymphoma cases and matched controls) from within an existing prospective cohort to efficiently test an expensive biomarker.
2
Determine the appropriate statistical measure for this design.
Odds ratio.
Studies that sample based on outcome (case-control) compare the odds of exposure between groups; they cannot calculate relative risk or absolute risk directly.
3
Evaluate the specific biases mitigated by this design.
Recall bias and temporal ambiguity are minimized.
The exposure data (frozen blood for biomarker X) was collected prospectively, before the outcome occurred.

Anahtar Kavram

Nested Case-Control Study Design
Soru 4070Soru →

Match each clinical research scenario or calculated parameter to the specific epidemiological metric it best represents.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A randomized controlled trial compares a new anticoagulant to a placebo. The experimental group has a 4% rate of major gastrointestinal bleeding, while the placebo group has a 2% rate. The value 50 indicates the number of patients who must be treated to cause one additional major bleeding event.
A prospective cohort study follows 5,000 initially healthy adults for 10 years. During this time, 250 individuals are newly diagnosed with type 2 diabetes. The value of 5% represents the probability of developing the disease over the specified time period.
A state health department conducts a survey on a single day and finds that 50,000 out of 500,000 residents have a diagnosis of major depressive disorder. The value of 10% describes the burden of disease at that exact time.
Epidemiologists estimate that if radon gas exposure were eliminated from all homes, the total incidence of lung cancer in the general population would decrease by 15%. This percentage describes the proportion of disease incidence linked to this exposure.
In a clinical trial for a novel biologic therapy, the risk of joint destruction is 12% in the treatment group and 16% in the placebo group. The value of 25% describes the proportional decrease in risk associated with the therapy.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

1 matches with Number needed to harm (NNH); 2 matches with Cumulative incidence; 3 matches with Point prevalence; 4 matches with Population attributable risk percent (PAR%); 5 matches with Relative risk reduction (RRR).
Each scenario uniquely outlines the mathematical calculation and clinical application of a specific epidemiological concept. Number Needed to Harm (NNH) measures the adverse impact of an intervention based on absolute risk increase. Cumulative incidence tracks new diagnoses within a defined timeframe. Point prevalence captures a statistical snapshot of existing cases. Population attributable risk percent (PAR%) measures the broad population-level impact of removing an exposure. Relative risk reduction (RRR) quantifies the proportional clinical benefit of an intervention compared to baseline risk.

Adım Adım Çözüm

1
Evaluate the anticoagulant trial scenario.
Matches with Number needed to harm (NNH).
The scenario describes the calculation of the reciprocal of the absolute risk increase (4% - 2% = 2%; 1 / 0.02 = 50), which defines the NNH.
2
Evaluate the prospective cohort study scenario.
Matches with Cumulative incidence.
The scenario calculates the number of new cases developing over time divided by an initial at-risk population, which is the definition of cumulative incidence.
3
Evaluate the single-day survey scenario.
Matches with Point prevalence.
The scenario calculates existing cases over the total population at an exact point in time, measuring disease burden as point prevalence.
4
Evaluate the radon gas elimination scenario.
Matches with Population attributable risk percent (PAR%).
The scenario describes the percentage of total incidence in the general population that can be attributed to and potentially prevented by eliminating a specific exposure.
5
Evaluate the biologic therapy trial scenario.
Matches with Relative risk reduction (RRR).
The scenario calculates the proportional reduction in adverse outcomes relative to the control group risk ((16% - 12%) / 16% = 25%).

Anahtar Kavram

Measures of Disease Frequency and Association
Tahmini Süre:2m 0s
Soru 4071Soru →

Match each post-operative cardiothoracic surgery complication to its characteristic clinical presentation or diagnostic finding.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Phrenic nerve injury
Thoracic duct injury
Recurrent laryngeal nerve injury
Postpericardiotomy syndrome

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Phrenic nerve injury pairs with elevated hemidiaphragm; Thoracic duct injury pairs with milky pleural effusion; Recurrent laryngeal nerve injury pairs with new-onset hoarseness; Postpericardiotomy syndrome pairs with late-onset fever and friction rub.
Each complication has a distinct anatomical or physiological basis directly tied to the surgical field: the phrenic nerve controls the diaphragm, the thoracic duct transports triglyceride-rich chyle, the recurrent laryngeal nerve controls the vocal cords, and the pericardium can undergo a delayed autoimmune inflammatory response.

Adım Adım Çözüm

1
Identify the anatomical relationships and physiological consequences of each cardiothoracic complication.
Recognized the specific nerve distributions, lymphatic drainage pathways, and immune responses associated with thoracic surgical procedures.
Matching complications requires understanding the distinct pathophysiology of structures vulnerable during cardiothoracic surgery.

Anahtar Kavram

Recognition of common anatomical and physiological complications following cardiothoracic surgery.
Soru 4072Soru →

Following a mountain biking accident, a 32-year-old man arrives at the emergency department reporting severe perineal pain. He fell forcefully onto the crossbar of his bicycle 2 hours ago and has been unable to void since the incident. Vital signs are temperature 37.0°C (98.6°F), blood pressure 130/80 mm Hg, and pulse 88/min. Inspection of the genital region reveals pronounced swelling and a characteristic butterfly-shaped ecchymosis confined to the perineum. A distinct drop of blood is visualized at the urethral meatus. Digital rectal examination demonstrates a non-tender, normally positioned prostate with intact rectal tone. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Perform retrograde urethrography

Cevap

The most appropriate next step is to perform retrograde urethrography.
The patient presents with classic signs of an anterior (bulbar) urethral injury, characterized by a straddle mechanism, blood at the urethral meatus, and a butterfly-shaped perineal ecchymosis. In any patient with suspected urethral trauma, retrograde urethrography must be performed to evaluate urethral integrity before attempting to insert a transurethral catheter.

Adım Adım Çözüm

1
Analyze the mechanism of injury and physical exam findings.
The patient experienced a straddle injury resulting in perineal pain, inability to void, blood at the urethral meatus, and a butterfly-shaped perineal ecchymosis.
These findings are classic for an anterior urethral injury (specifically, the bulbar urethra). The butterfly pattern occurs when Buck's fascia is torn, allowing blood and urine to extravasate into the superficial perineal space contained by Colles' fascia.
2
Determine the safest diagnostic sequence for a suspected urethral injury.
Retrograde urethrography must be selected before any attempt at passing a urethral catheter.
Blind catheterization can convert a partial urethral tear into a complete transection, causing severe iatrogenic harm. Contrast imaging safely maps the defect.

Anahtar Kavram

Diagnosis and management of anterior urethral trauma
Soru 4073Soru →

An emergency medical team brings a 6-year-old female to the trauma bay after she sustained a fall from a playground structure onto an outstretched left arm. She is crying and refusing to move her left upper extremity. Physical examination reveals a significant "S-shaped" deformity and severe swelling around the left elbow. The left hand is pale and cool to the touch. Capillary refill is 4 seconds. Radial and ulnar pulses are absent on palpation and cannot be detected with a handheld Doppler. She is unable to flex the interphalangeal joint of her thumb. Radiographs confirm a completely displaced, extension-type supracondylar humerus fracture. Arrange the following management steps in the most appropriate chronological order for this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The most appropriate chronological order is to first position the elbow in relative extension, followed by closed reduction and percutaneous pinning. After skeletal stabilization, perfusion must be reassessed. If the hand remains ischemic, surgical exploration of the antecubital fossa is performed, followed by a prophylactic volar forearm fasciotomy.
The correct sequence dictates that the mechanical cause of vascular compromise (the displaced fracture) must be addressed first. Initial repositioning (slight extension) prevents further tethering. Closed reduction and pinning unkinks the brachial artery. Only if the limb remains ischemic after reduction is vascular exploration warranted, which in turn necessitates a prophylactic fasciotomy due to reperfusion injury risks.

Adım Adım Çözüm

1
Recognize the "pink, pulseless" vs "pale, pulseless" supracondylar fracture presentation.
The patient has a "pale, pulseless" hand (ischemic limb), which is an absolute orthopedic emergency.
An ischemic limb requires immediate intervention to prevent irreversible muscle and nerve necrosis.
2
Determine the initial emergency department maneuver.
Position the elbow in 20-30 degrees of extension.
Hyperflexion exacerbates vascular kinking over the fracture site. Slight extension can temporarily improve flow while awaiting the operating room.
3
Identify the definitive first-line operative intervention.
Closed reduction and percutaneous pinning.
The brachial artery is typically tethered or kinked by the proximal fracture fragment, not severed. Anatomic reduction unkinks the artery and restores flow in the vast majority of cases. Angiography is contraindicated as it delays reduction.
4
Establish criteria for further operative steps.
Reassess perfusion; if still ischemic, perform vascular exploration and prophylactic fasciotomy.
If the hand remains white and pulseless after the fracture is pinned, the artery may be entrapped in the fracture site or severely damaged, necessitating anterior exploration and subsequent compartment release.

Anahtar Kavram

Algorithm for managing a pulseless pediatric supracondylar humerus fracture.
Tahmini Süre:1m 30s
Soru 4074Soru →

Match each urologic oncology clinical presentation with the most appropriate definitive surgical or procedural intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old man has an incidentally discovered 3.5 cm enhancing solid mass confined to the lower pole of the left kidney. His baseline estimated glomerular filtration rate is 95 mL/min.
A 68-year-old woman has an 11 cm right renal mass with tumor extension into the renal vein and infrahepatic inferior vena cava, with no evidence of distant metastasis.
A 32-year-old man presents with a painless, firm right testicular nodule; serum alpha-fetoprotein and beta-hCG levels are markedly elevated, and scrotal ultrasound confirms a hypoechoic intratesticular mass.
A 62-year-old man with gross hematuria is found to have a 2 cm papillary bladder tumor; pathology from the initial biopsy reveals high-grade urothelial carcinoma limited to the mucosa without lamina propria invasion.
A 70-year-old woman with gross hematuria undergoes bladder biopsy, which reveals high-grade urothelial carcinoma invading the muscularis propria (detrusor muscle), with negative staging scans for metastasis.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align specific tumor stages and anatomical locations with their gold-standard surgical interventions: small renal mass to partial nephrectomy, large renal mass with venous involvement to radical nephrectomy with thrombectomy, testicular mass to radical inguinal orchiectomy, superficial bladder tumor to TURBT with BCG, and muscle-invasive bladder tumor to radical cystectomy.
Each pairing represents the standard-of-care surgical or procedural intervention for distinct urologic malignancies based on current urologic oncology guidelines, primarily determined by the depth of invasion, tumor size, and anatomical location.

Adım Adım Çözüm

1
Analyze the renal mass scenarios.
The 3.5 cm lower pole mass is a clinical T1a lesion, warranting partial nephrectomy. The 11 cm mass with IVC extension is a locally advanced lesion, requiring radical nephrectomy and thrombectomy.
Surgical management of renal cell carcinoma depends heavily on tumor size and the presence of venous extension.
2
Evaluate the testicular nodule scenario.
The presentation with elevated tumor markers and an intratesticular mass dictates a radical inguinal orchiectomy.
Testicular cancer must be removed intact via the inguinal canal to prevent lymphatic spread to the scrotum.
3
Compare the two bladder cancer scenarios.
The first is non-muscle-invasive (mucosa only) and is paired with TURBT and BCG. The second is muscle-invasive (detrusor involvement) and is paired with radical cystectomy.
The depth of invasion into the bladder wall is the critical inflection point that determines whether the bladder can be saved or must be completely removed.

Anahtar Kavram

Surgical management of urologic malignancies based on anatomic site and clinical staging
Tahmini Süre:2m 0s
Soru 4075Soru →

Match each clinical scenario involving the biliary tract with the most appropriate surgical or endoscopic intervention.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient develops high-volume bilious output from a surgical drain on postoperative day 3 following an uncomplicated elective laparoscopic cholecystectomy. Imaging shows no retained common bile duct stones.
During a difficult cholecystectomy for severe gangrenous cholecystitis, the common bile duct is inadvertently completely transected, resulting in a 2.5-centimeter gap between the proximal and distal duct ends.
A patient with recurrent cholangitis is found to have a 1.5-centimeter impacted common bile duct stone. Endoscopic retrograde cholangiopancreatography (ERCP) is performed, but the stone cannot be captured or fragmented.
An abdominal ultrasound performed for vague epigastric discomfort incidentally reveals a 2.2-centimeter sessile, non-mobile polypoid mass projecting into the gallbladder lumen.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matching aligns a minor postoperative leak with ERCP, a major biliary transection with Roux-en-Y hepaticojejunostomy, a refractory CBD stone with surgical common bile duct exploration, and a large, suspicious gallbladder polyp with extended cholecystectomy.
Each scenario requires a specific stepwise intervention based on standard surgical protocols: ERCP for minor leaks, Roux-en-Y for large anatomic defects, surgical exploration for endoscopically unretrievable stones, and oncologic resection for suspected gallbladder malignancy.

Adım Adım Çözüm

1
Evaluate the postoperative bile leak scenario.
Identified as a likely cystic duct stump leak that requires ERCP.
ERCP with stenting reduces biliary tree pressure, preferentially diverting bile flow away from the leak site and allowing it to heal without major surgery.
2
Analyze the major ductal injury scenario.
Identified a 2.5-cm common bile duct gap requiring Roux-en-Y hepaticojejunostomy.
Primary repair of a large ductal gap is contraindicated due to ischemia and stricture risk; biliary-enteric drainage is mandatory for definitive reconstruction.
3
Assess the refractory choledocholithiasis scenario.
Identified failure of ERCP necessitating laparoscopic common bile duct exploration.
Surgical common bile duct exploration is the standard fallback when advanced endoscopic techniques fail to clear a large, impacted stone.
4
Evaluate the large gallbladder polyp scenario.
Identified a 2.2-cm polyp highly suspicious for malignancy requiring extended cholecystectomy.
To provide an adequate oncologic resection, extended cholecystectomy including the gallbladder bed and regional lymph nodes is required for polyps >2 cm.

Anahtar Kavram

Management of complex biliary tract disease and iatrogenic biliary injuries
Soru 4076Soru →

Match each clinical quality improvement scenario with the most appropriate corresponding framework or model.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A hospital committee retrospectively investigates a sentinel event where a patient underwent surgery on the wrong extremity to identify underlying systemic causes.
A multidisciplinary team prospectively evaluates a new automated intravenous pump system to identify potential points of failure prior to hospital-wide implementation.
An outpatient clinic implements a new diabetic screening protocol for two weeks, measures the screening rate, and adjusts the workflow before expanding to all patients.
A medication error reaches a patient due to the simultaneous alignment of a physician prescribing error, a pharmacist verification oversight, and a nurse administration mistake.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Retrospective investigations align with Root Cause Analysis; proactive evaluations align with Failure Mode and Effects Analysis; small-scale iterative tests align with the Plan-Do-Study-Act cycle; and the alignment of multiple systemic failures aligns with the Swiss cheese model.
Each clinical scenario describes the classical application or definition of a primary quality improvement framework. Retrospective review of an event requires RCA, forward-looking risk mitigation requires FMEA, iterative real-world testing utilizes PDSA, and the theory of aligned systemic vulnerabilities is depicted by the Swiss cheese model.

Adım Adım Çözüm

1
Analyze the first scenario involving a retrospective investigation of a wrong-site surgery.
Matches with Root Cause Analysis (RCA).
RCA is specifically designed to look backward after a sentinel event to find the systemic root causes.
2
Analyze the second scenario involving a prospective evaluation of a new intravenous pump system.
Matches with Failure Mode and Effects Analysis (FMEA).
FMEA is used proactively to anticipate and prevent potential failures before a new system is implemented.
3
Analyze the third scenario describing a two-week trial of a new protocol, followed by measurement and adjustment.
Matches with Plan-Do-Study-Act (PDSA) cycle.
The PDSA cycle involves planning a change, doing a small test, studying the results, and acting on the findings.
4
Analyze the fourth scenario describing the simultaneous failure of physician, pharmacist, and nurse safeguards.
Matches with the Swiss cheese model.
The Swiss cheese model explains that patient harm occurs when holes (vulnerabilities) in multiple defensive layers align.

Anahtar Kavram

Patient Safety and Quality Improvement Core Frameworks
Soru 4077Soru →

A 55-year-old woman presents to the surgical clinic for evaluation of a neck mass that she noticed two weeks ago while swallowing. She reports a 6-month history of profound fatigue, cold intolerance, dry skin, and a 4.5-kg (10-lb) weight gain. Her past medical history is significant for a severe postpartum hemorrhage requiring multiple blood transfusions 20 years ago. She takes no daily medications. Her temperature is 36.5°C (97.7°F), blood pressure is 110/70 mmHg, and pulse is 58/min. Physical examination reveals a 2.5-cm, firm, non-tender, mobile nodule in the right lobe of the thyroid gland. There is no cervical lymphadenopathy.

Laboratory studies show:
TestResultNormal Range
Thyroid-stimulating hormone (TSH)0.1 mIU/L0.4–4.0 mIU/L
Free T40.5 ng/dL0.9–1.7 ng/dL

Ultrasound of the neck demonstrates a 2.5-cm solid, markedly hypoechoic nodule with irregular margins in the right thyroid lobe. Which of the following is the most appropriate next step in the management of this patient's thyroid nodule?

Cevabı ve açıklamayı göster

Cevap: Fine-needle aspiration biopsy of the thyroid nodule

Cevap

Fine-needle aspiration biopsy of the thyroid nodule
The standard diagnostic workup for a newly discovered thyroid nodule begins with a serum TSH. Typically, a low TSH prompts a radionuclide thyroid scan to identify a 'hot' nodule. However, this patient's labs (low TSH and low free T4) and clinical history (postpartum hemorrhage, fatigue, weight gain) are diagnostic of central (secondary) hypothyroidism, likely Sheehan syndrome. Because her thyroid gland is not autonomously hyperfunctioning, a radionuclide scan will not provide useful information regarding a 'hot' nodule. Therefore, the nodule must be evaluated strictly based on ultrasound features. The patient's nodule is 2.5 cm, solid, markedly hypoechoic, and has irregular margins—all highly suspicious features for thyroid malignancy. The appropriate next step is a fine-needle aspiration biopsy to evaluate for thyroid cancer.

Adım Adım Çözüm

1
Interpret the laboratory findings.
The patient has both a low TSH (0.1 mIU/L) and a low free T4 (0.5 ng/dL).
This laboratory pattern indicates central (secondary) hypothyroidism, rather than primary hyperthyroidism, which is further supported by her history of postpartum hemorrhage (Sheehan syndrome) and hypothyroid symptoms.
2
Determine the appropriate algorithm for the thyroid nodule.
The nodule must be evaluated using standard ultrasound criteria, bypassing the radionuclide scan.
Although the TSH is low, the thyroid gland is not autonomously functioning. Therefore, a radionuclide scan is not indicated, as the low TSH is driven by pituitary failure, not an autonomous 'hot' nodule.
3
Evaluate the ultrasound features to determine the final next step.
The nodule is 2.5 cm, solid, markedly hypoechoic, and has irregular margins.
These are highly suspicious sonographic features for malignancy, making a fine-needle aspiration (FNA) biopsy explicitly indicated to establish a tissue diagnosis.

Anahtar Kavram

In patients with a thyroid nodule and central hypothyroidism (low TSH, low Free T4), the low TSH does not indicate an autonomously functioning thyroid gland. Therefore, a radionuclide scan is bypassed, and the nodule is evaluated with fine-needle aspiration biopsy based on sonographic criteria.
Soru 4078Soru →

A 35-year-old man comes to the clinic to establish care. He has no significant past medical history and takes no medications. The patient reports a history of intravenous drug use in his early twenties but has been in recovery for the past 10 years. Physical examination is unremarkable. He is interested in undergoing appropriate health screenings. Arrange the following clinical steps in the correct chronological order for the screening, diagnosis, and management of the infectious disease most strongly associated with his risk factors.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: HCV antibody testing, followed by HCV RNA testing, followed by assessment of liver fibrosis and Hepatitis A/B immunity, followed by initiation of DAA therapy, and finally measuring HCV RNA for SVR 12 weeks after completing therapy.
The sequence follows the evidence-based clinical cascade for Hepatitis C. The first step is the screening HCV antibody test. Because antibodies persist even after spontaneous clearance, a positive antibody test must always be followed by an HCV RNA PCR test to confirm active viremia. Once active chronic HCV is diagnosed, a critical pre-treatment evaluation is required. This involves staging the liver fibrosis (to determine regimen duration and necessity of future cancer screening) and checking Hepatitis A and B serologies (to vaccinate if necessary and prevent fatal HBV reactivation). After this workup is complete, patients are started on highly curative direct-acting antiviral (DAA) therapy. The final step in the sequence is confirming the cure, which is done by checking the HCV RNA level 12 weeks after finishing the medication to document a sustained virologic response (SVR).

Adım Adım Çözüm

1
Identify the patient's screening needs based on his demographics and history.
The patient has a history of intravenous drug use, placing him at high risk for Hepatitis C. The first step in evaluation is the HCV antibody screening test.
Current USPSTF guidelines recommend routine HCV screening for all adults, starting with an antibody test to detect prior exposure.
2
Determine the necessary confirmatory test following a positive screening result.
Quantitative HCV RNA PCR testing must be ordered.
A positive antibody test only indicates exposure. Up to 25% of patients clear the virus spontaneously; RNA testing is required to confirm an active, ongoing infection.
3
Establish the required pre-treatment workup for confirmed chronic HCV.
Liver fibrosis must be staged, and immunity against Hepatitis A and B must be verified.
Fibrosis staging dictates the duration of therapy and the need for future liver cancer surveillance. Hepatitis B status must be known because treating HCV can trigger a dangerous reactivation of HBV.
4
Select the appropriate definitive intervention.
Initiate an oral direct-acting antiviral (DAA) regimen.
DAAs are the standard of care for treating chronic HCV, offering cure rates exceeding 95%.
5
Define the method for determining treatment success.
Measure HCV RNA 12 weeks post-treatment.
An undetectable viral load 12 weeks after stopping therapy is known as a sustained virologic response (SVR) and is considered a definitive cure.

Anahtar Kavram

The Hepatitis C care cascade involves initial antibody screening, confirmatory RNA testing, essential pre-treatment evaluation (including fibrosis staging and HBV/HAV immunity assessment), DAA therapy, and a test of cure (SVR12).
Soru 4079Soru →

A major academic medical center is evaluating the clinical utility of a novel continuous biomarker assay for the detection of early-stage pancreatic adenocarcinoma. The laboratory and clinical epidemiology teams are analyzing how different implementations and assay modifications will affect the test's performance metrics. Match each operational change or population shift (left) with its corresponding mathematical impact on the test's epidemiological characteristics (right). Assume higher biomarker values correlate with a higher probability of disease.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Decreasing the diagnostic cutoff threshold for a positive test result
Raising the diagnostic cutoff threshold for a positive test result
Deploying the assay in an asymptomatic, average-risk screening population instead of a high-risk referral clinic
Using the assay strictly as a sequential confirmatory test only for patients who tested positive on an initial, highly sensitive screening test
Adopting an updated assay generation that achieves a greater area under the receiver operating characteristic (ROC) curve, while clamping the false-positive rate at its original value

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Decreasing the cutoff matches with a decreased false-negative rate but lower positive predictive value. Raising the cutoff matches with a decreased false-positive rate and higher positive predictive value, but an increased false-negative rate. Applying the test to an average-risk population matches with a decreased positive predictive value and increased negative predictive value without altering inherent accuracy. Sequential testing matches with an increased pre-test probability leading to a higher positive predictive value. Improving the ROC curve while clamping the false-positive rate matches with increased sensitivity without changing specificity.
Each operational or population shift mathematically dictates specific changes in test performance parameters. Cutoff shifts force a trade-off between sensitivity and specificity; prevalence changes alter predictive values without affecting inherent test accuracy; and ROC curve improvements increase sensitivity when specificity is clamped.

Adım Adım Çözüm

1
Analyze the effect of altering the diagnostic cutoff thresholds.
Decreasing the cutoff categorizes more patients as positive. This increases sensitivity (decreasing the false-negative rate), but decreases specificity (increasing the false-positive rate), lowering the positive predictive value (PPV). Raising the cutoff categorizes fewer patients as positive. This increases specificity (decreasing the false-positive rate) and raises PPV, but decreases sensitivity (increasing the false-negative rate).
Cutoff threshold shifts always mandate a direct mathematical trade-off between sensitivity and specificity, which subsequently alters the predictive values.
2
Evaluate the impact of shifting the population prevalence.
Applying the test to an average-risk screening population lowers disease prevalence, which directly decreases PPV and increases negative predictive value (NPV) without altering inherent test accuracy. Using the test strictly as a sequential second-line screen creates a cohort with a much higher pre-test probability, directly increasing the PPV.
Predictive values (PPV and NPV) are heavily dependent on the prevalence (pre-test probability) of the disease in the tested population, whereas sensitivity and specificity are stable innate characteristics of the assay itself.
3
Determine the consequence of improving the area under the ROC curve.
An improved assay with a higher ROC area discriminates more effectively between healthy and diseased states. If the false-positive rate (and therefore specificity) is kept constant, the higher ROC curve dictates that the true-positive rate (sensitivity) must inherently increase.
The ROC curve plots Sensitivity on the y-axis against the False Positive Rate (1 - Specificity) on the x-axis. An upward and leftward shift in the overall curve yields a higher y-value for any given x-value.

Anahtar Kavram

Diagnostic test performance is dictated by cutoff thresholds (which determine the trade-off between sensitivity and specificity), assay discrimination accuracy (measured by the ROC AUC), and population prevalence (which directly drives predictive values).
Tahmini Süre:2m 0s
Soru 4080Soru →

A 4-year-old boy is brought to the clinic for a routine well-child preventive care visit. He was diagnosed with perinatal HIV infection and is currently taking antiretroviral therapy. Laboratory evaluation from last week shows a CD4 T-lymphocyte percentage of 12%. He has not received any immunizations since his 18-month well-child visit. His guardian asks to update his routine childhood vaccines so he can attend preschool. Which of the following vaccines is considered safe and most appropriate to administer to this patient today?

Cevabı ve açıklamayı göster

Cevap: Inactivated polio vaccine

Cevap

Inactivated polio vaccine
The correct answer is the inactivated polio vaccine. Routine childhood immunization is a critical component of clinical preventive services. In children with HIV, a CD4 T-lymphocyte percentage of less than 15% defines severe immunosuppression. Under these conditions, the administration of live-attenuated vaccines is strictly contraindicated because the patient's compromised cell-mediated immunity cannot safely control the replication of the attenuated virus, risking severe or fatal vaccine-strain disease. Conversely, inactivated, killed, or recombinant vaccines—such as the inactivated polio vaccine (IPV) and the intramuscular influenza vaccine—cannot replicate and are entirely safe for immunocompromised patients. Therefore, the inactivated polio vaccine should be administered to keep the patient on schedule for their 4-to-6-year-old preventive milestones.

Adım Adım Çözüm

1
Assess the patient's immune status based on the clinical vignette.
The patient has HIV with a CD4 percentage of 12%, which indicates severe immunosuppression.
Vaccine safety profiles differ significantly between immunocompetent and severely immunocompromised patients.
2
Determine the contraindications for immunizations in severely immunocompromised children.
Live-attenuated vaccines are strictly contraindicated due to the risk of uncontrolled vaccine-strain replication and severe disseminated infection.
The compromised immune system cannot adequately contain the live virus, even in its attenuated state.
3
Categorize the listed vaccine options into live-attenuated versus inactivated/recombinant types.
Measles, mumps, and rubella (MMR), varicella, intranasal influenza, and live typhoid vaccines are all live-attenuated. The polio vaccine provided is inactivated.
Identifying the only inactivated vaccine reveals the single safe option for this patient.

Anahtar Kavram

In pediatric patients with severe immunosuppression (e.g., HIV with CD4 < 15%), live-attenuated vaccines are strictly contraindicated, whereas inactivated vaccines are safe and routinely indicated for preventive care.
ÖncekiSayfa 204 / 414Sonraki
Tüm alıştırma soruları — USMLE Step 2 CK | Examkin